Table 2.
Descriptive information
| [18F]altanserin, n = 139 | [11C]‐Cimbi‐36, n = 28 | |||||
|---|---|---|---|---|---|---|
| Measures | Mean ± SD or % | Median | Range, min–max | Mean ± SD or % | Median | Range, min–max |
| Age in years | 38.7 ± 17.4 | 33.4 | 18.5–81.7 | 23.5 ± 5.1 | 22.8 | 18.4–46.1 |
| BMI kg/m2 | 24.1 ± 2.5 | 24.1 | 18.4–29.7 | 23.7 ± 2.7 | 23.1 | 20.6–30.6 |
| Sex (female) | 38% | 48% | ||||
| Education | 3.9 ± 1.3 | 4 | 1–5 | 3.8 ± 1.7 | 5 | 1–5 |
| Trait Openness | 115.5 ± 18.7 | 114 | 68–170 | 113.7 ± 19.7 | 111 | 68–160 |
| Injected dose MBq | 265.2 ± 55.4 | 272 | 155–412 | 499.9 ± 117.3 | 563.2 | 213–603.9 |
| Injected mass | 2.7 ± 2.3 | 2.1 | 0.2–11 | 0.8 ± 0.5 | 0.6 | 0.1–1.5 |
| Specific activity MBq/μmol | 79.8 ± 74.2 | 58.4 | 10.3–441.7 | 378.5 ± 275.5 | 249.3 | 95.4–1,033 |
| Neocortex 2A BP or BND | 1.5 ± 0.5 | 1.5 | 0.4–3.7 | 1.3 ± 0.2 | 1.3 | 0.8–1.7 |
| PET scanner (HRRT) | 32% | 100% | ||||
| Days from PET to NEO | 11.09 ± 40.28 | 0 | 0–314 | 11.2 ± 14.2 | 6 | 0–60 |
Note. Descriptive information about the study participants. SD = standard deviation, BMI = body mass index, MBq = megabecquerel, μmol = micromole, B P = binding potential, B ND = nondisplaceable binding potential, PET = positron emission tomography, NEO PI‐R = NEO Personality Inventory.